Ad-hoc | 26 May 2004 13:45

Geratherm awarded licence for Cardio Monitor

Ad-hoc-announcement transmitted by DGAP. The issuer is solely responsible for the content of this announcement. ——————————————————————————– DGAP-ad hoc: Geratherm Medical AG Geratherm awarded licence for Cardio Monitor 26th May 2004: After a 4-year period of development and the positive conclusion of the Third Clinical Study Geratherm Medical has been awarded a CE licence for its Cardio Monitor (AFD – Atrial Fibrillation Detector). The granting of the CE licence clears the way for the Cardio Monitor to be marketed internationally, except in the USA, Canada and Japan. The Cardio Monitor enables atrial fibrillation to be detected within 60 minutes with a probability rate of over 90%. Thirty per cent of all strokes are attributable to the presence of atrial fibrillation. There are more than 300,000 stroke patients per year in Germany. Geratherm Medical AG, listed on the Prime Standard, develops, produces and sells systems for the measurement and transmission of vital parameters. Geratherm Medical AG, Fahrenheitstraße 1, D-98716 Geschwenda Editing contact: Martina Schramm, phone: ++49(0)36205/98 111, fax: ++49(0)36205/98 115 E-mail: info@geratherm.com – end of message end of ad-hoc-announcement (c)DGAP 26.05.2004 ——————————————————————————– WKN: 549562; ISIN: DE0005495626; Index: Listed: Amtlicher Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin- Bremen, Düsseldorf, Hamburg, München und Stuttgart 261345 Mai 04